Targeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy
Open Access
- 22 November 2025
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Abstract
Cuproptosis, a newly identified form of cell death, is closely linked to copper homeostasis and protein lipoylation. Using a multi-omics approach, we firstly reveal that SERPINB3 confers cuproptosis resistance in pancreatic cancer and functions as a theranostic biomarker. Mechanistically, SERPINB3 inhibits FDX1 transcription by activating the MAPK signaling pathway, thereby conferring cuproptosis resistance. We further demonstrated that SERPINB3 directly interacts with MEK1, impeding its chaperone-mediated autophagic degradation, which ultimately leads to sustained activation of the MAPK signaling pathway. Additionally, we found that SERPINB3 promotes pancreatic cancer immune evasion by upregulating PD-L1 expression on tumor cells. This phenomenon motivated the development of a triple-combination strategy consisting of MAPK inhibition, cuproptosis induction, and αPD-1 therapy for pancreatic cancer patients with high SERPINB3 expression. To this end, we further developed a metal-organic framework (MOF) loaded with both copper ions and MEK inhibitor, which significantly triggers tumor-specific cuproptosis and enhances antitumor immunity. In summary, SERPINB3 serves as a predictive biomarker to inform therapeutic strategies targeting cuproptosis, thereby establishing a novel paradigm for cancer immunotherapy that integrates metal biology, targeted therapy, and immune modulation.Keywords
Funding Information
- Fujian Provincial Health Science and Technology Plan Project, Youth and Middle-aged Talent Training Project (2021GGA006)
- National Natural Science Foundation of China (82503412)
- National Natural Science Foundation of China (82473009)
- Fujian province science and technology innovation joint fund project (2024Y9070)
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0525500/2024ZD0525502)
- Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare (No.2021(60))
- National Outstanding Young Physicians Talent Program
This publication has 65 references indexed in Scilit:
- Extracellular vesicles miR‐31‐5p promotes pancreatic cancer chemoresistance via regulating LATS2‐Hippo pathway and promoting SPARC secretion from pancreatic stellate cellsJournal of Extracellular Vesicles, 2024
- Self‐Destructive Copper Carriers Induce Pyroptosis and Cuproptosis for Efficient Tumor Immunotherapy Against Dormant and Recurrent TumorsAdvanced Materials, 2023
- Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer ImmunotherapyAdvanced Materials, 2023
- ZIF‐8 Nanoparticles Evoke Pyroptosis for High‐Efficiency Cancer ImmunotherapyAngewandte Chemie International Edition, 2023
- Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapyActa Biomaterialia, 2022
- Pancreatic CancerJAMA, 2021
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal AdenocarcinomaJAMA Oncology, 2019
- KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinomaCancer Immunology, Immunotherapy, 2017
- Changes in the Serum Levels of Trace Elements Before and After the Operation in Thyroid Cancer PatientsBiological Trace Element Research, 2016
- Serum total oxidant/antioxidant status and trace element levels in breast cancer patientsInternational Journal of Clinical Oncology, 2011